SLC HEALTH STRATEGIES, LLC

Government Relations - Lobbying/Consulting

Filings
38
Clients
4
Total Income
$1,326,000
Years Active
2013–2015

Filings

Year Client Period Income Expenses Doc
2015 NOVO NORDISK PHARMACEUTICALS, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$22,500
2015 NOVO NORDISK PHARMACEUTICALS, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$22,500
2015 NOVO NORDISK PHARMACEUTICALS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$22,500
2015 EISAI INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Termination (No Activity)
2015 NOVO NORDISK PHARMACEUTICALS, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$22,500
2015 EISAI INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$40,500
2014 NOVO NORDISK PHARMACEUTICALS, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$27,000
2014 EISAI INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$40,500
2014 CUBIST PHARMACEUTICALS, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$60,000
2014 NOVO NORDISK PHARMACEUTICALS, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$27,000
Page 1 of 4  ·  38 filings Next

Clients Represented

ClientFilingsTotal Income
NOVO NORDISK PHARMACEUTICALS, INC. 13 $288,000
EISAI INC. 11 $378,000
CUBIST PHARMACEUTICALS, INC. 9 $480,000
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY 5 $180,000

Lobbyists

NameDisclosed Prior Position
SHARON COHEN

Affiliated Organizations

NOVO NORDISK A/S
Copenhagen, DK
TAKEDA PHARMACEUTICAL COMPANY LTD.
Chuo-ku, Tokyo 103-8668, JP